FDA Inspection 1191048 — AJES Pharmaceuticals, LLC

AJES Pharmaceuticals, LLC — FEI 3001848656

The FDA completed an inspection of AJES Pharmaceuticals, LLC on November 21, 2022 in Copiague, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 21, 2022
Fiscal Year
2023
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Copiague, NY (United States)

Citations

IDCFRDescription
1549821 CFR 111.27(d)Equipment - maintain, clean, sanitize
1554721 CFR 111.260(g)Batch record - results; monitoring
1568121 CFR 111.315(d)Standard reference materials; criteria for selecting
1575321 CFR 111.210(b)Master manufacturing record - list components
1586921 CFR 111.75(c)Specifications met - verify; finished batch